Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study.
oral anticoagulant drugs
oral antiplatelet drugs
primary health care
secondary stroke prevention
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
28 Sep 2021
28 Sep 2021
Historique:
received:
01
08
2021
revised:
12
09
2021
accepted:
21
09
2021
entrez:
13
10
2021
pubmed:
14
10
2021
medline:
14
10
2021
Statut:
epublish
Résumé
The purpose of the study was to evaluate secondary stroke prevention in Poland and its association with sociodemographic factors, place of residence, and concomitant cardiovascular risk factors. From all patients in LIPIDOGRAM2015 Study ( 165 subjects (61.6%) used at least one preventive medication. Oral antiplatelet and anticoagulation agents were used by 116 (43.3%) and 70 (26.1%) patients, respectively. Only 157 (58.6%) participants used lipid-lowering drugs, and 205 (76.5%) were treated with antihypertensive drugs. Coronary heart disease (CHD) and dyslipidaemia were associated with antiplatelet treatment ( In Poland drugs and lifestyle modification for secondary stroke prevention are not commonly adhered to. Educational programmes for physicians and patients should be developed to improve application of effective secondary prevention of stroke.
Sections du résumé
BACKGROUND
BACKGROUND
The purpose of the study was to evaluate secondary stroke prevention in Poland and its association with sociodemographic factors, place of residence, and concomitant cardiovascular risk factors.
MATERIAL AND METHODS
METHODS
From all patients in LIPIDOGRAM2015 Study (
RESULTS
RESULTS
165 subjects (61.6%) used at least one preventive medication. Oral antiplatelet and anticoagulation agents were used by 116 (43.3%) and 70 (26.1%) patients, respectively. Only 157 (58.6%) participants used lipid-lowering drugs, and 205 (76.5%) were treated with antihypertensive drugs. Coronary heart disease (CHD) and dyslipidaemia were associated with antiplatelet treatment (
CONCLUSIONS
CONCLUSIONS
In Poland drugs and lifestyle modification for secondary stroke prevention are not commonly adhered to. Educational programmes for physicians and patients should be developed to improve application of effective secondary prevention of stroke.
Identifiants
pubmed: 34640490
pii: jcm10194472
doi: 10.3390/jcm10194472
pmc: PMC8509736
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Valeant Pharmaceuticals International
ID : Educational grant
Références
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
J Am Coll Nutr. 2015;34(5):408-15
pubmed: 25826615
Stroke. 2010 Feb;41(2):397-401
pubmed: 20075360
J Am Heart Assoc. 2018 May 17;7(11):
pubmed: 29773578
Neurol Neurochir Pol. 2017 Sep - Oct;51(5):382-387
pubmed: 28756016
Neurol Neurochir Pol. 2018 Mar;52(2):252-262
pubmed: 29221869
Arch Med Sci. 2020 Mar 02;16(2):237-252
pubmed: 32190133
BMC Cardiovasc Disord. 2012 Oct 31;12:98
pubmed: 23114009
Arch Neurol. 1992 Aug;49(8):857-63
pubmed: 1524519
N Engl J Med. 2018 Dec 20;379(25):2429-2437
pubmed: 30575491
Arch Med Sci. 2019 Mar;15(2):385-392
pubmed: 30899291
Stroke. 2014 Jul;45(7):2160-236
pubmed: 24788967
Pharmacol Res. 2017 Aug;122:105-117
pubmed: 28602797
Comput Math Methods Med. 2020 Jun 1;2020:3217356
pubmed: 32565878
Am Fam Physician. 2017 Oct 1;96(7):436-440
pubmed: 29094912
N Engl J Med. 2013 Apr 4;368(14):1279-90
pubmed: 23432189
Med Clin North Am. 2019 Mar;103(2):295-308
pubmed: 30704682
Stroke. 1982 May-Jun;13(3):290-5
pubmed: 7080120
Stroke. 2021 Jul;52(7):e364-e467
pubmed: 34024117
BMC Neurol. 2017 Feb 6;17(1):24
pubmed: 28166784
PLoS One. 2020 Mar 2;15(3):e0226766
pubmed: 32119685
Stroke. 2018 Mar;49(3):e46-e110
pubmed: 29367334
J Stroke Cerebrovasc Dis. 2017 Dec;26(12):2806-2813
pubmed: 28823491
Lancet Neurol. 2019 May;18(5):439-458
pubmed: 30871944
Int J Epidemiol. 2019 Dec 1;48(6):1824-1838
pubmed: 31056682
Vasc Health Risk Manag. 2010 Oct 21;6:943-56
pubmed: 21057579
Atheroscler Suppl. 2020 Dec;42:e15-e24
pubmed: 33589219
Stroke. 2010 Jul;41(7):1338-42
pubmed: 20522818
Atherosclerosis. 2020 Nov;312:16-22
pubmed: 32947222
Lancet. 2001 Sep 29;358(9287):1033-41
pubmed: 11589932
Cardiovasc Res. 2019 Mar 1;115(3):e26-e31
pubmed: 30605511
Neurol Neurochir Pol. 2014;48(2):85-90
pubmed: 24821632
Circ Cardiovasc Qual Outcomes. 2018 Jan;11(1):e003228
pubmed: 29321134